Embed Size (px)
Citation preview
Investor Presentation April 2019
LED Investor PresentationMay 30, 2019
1
Safe Harbour Statement
We provide proprietary imaging software, software as a service and device solutions to Dentists, Dental Support Organizations (DSOs) & the US Military Dental Command
What We Do
VELscope® Vx
• Early oral mucosal disease detection using tissue autofluorescence
• Adjunct to Oral Cancer screening• Global category leader • Repeatable consumable revenue
TUXEDOTM Sensor
• Digital intraoral x-ray sensor• HD Resolution • Seamless integration with Apteryx SW
Apteryx Software
• XrayVision® – Client Server • XrayVision® DCV - Enterprise• XVWeb® - SaaS
Our Proprietary Imaging Solutions
XVWeb® Software as a Service (SaaS)
Total Addressable Market = 200,590 Dentists in 2018
Segmented Addressable Market = 17,651 DSO* affiliated
DSOs = 9% of total practices in the U.S. with CAGR of 14%
US market for dental imaging is world’s largest and growing with market estimated to exceed $1.7B by 2020*
*Dental Service Organizations182,939
17,651
US DENTISTS (2017)Non DSO DSO Solo or Group
*Source iDATA 2016
U.S. Market Opportunity
Patented imaging software solutions unlock our target market from “closed” proprietary competitive systems to open DICOM* standard – allowing freedom of choice for our clients
XVWeb SaaS provides single data base solution for image viewing, storage, analysis, and sharing from any web enabled device• Solves image accessibility issues and reduces IT costs
Unique imaging solutions for GPs, DSOs and Government customers and “in demand” solutions for cloud based dental practice management providers
Solving Customer Challenges
*Digital Imaging and Communications in Medicine
Recurring revenue contribution forecast to grow to $4.1M in FY19 from:
• XVWeb SaaS subscriptions• Software Maintenance and Support• VELcare support and VELscope consumable sales
Recurring / Repeatable Revenue Growth
Revenue $14.2M an increase of 12% over FY17
Gross Margin of 61% up from 56% in prior year
EBITDA $99k
• Net of one-time expense of $172k to exit property lease and $355k expense in relation to Oct 2017 preferred share financing
• $1.7M EBITDA improvement over prior year
FY18 Financial Highlights (USD)
Continued XVWeb market penetration and introduction of value added SaaS modules
Expansion of Software Maintenance & Support program within current customer base
US Government sales - leveraging current US Military relationship to include device sales
Opportunities related to large data lake for deep machine learning and data analytics
International expansion
0
Growth Opportunities
Growing revenue and gross margin percent
Strengthened financial position, positive EBITDA in 2018 with recurring revenue growth• Q1 FY19 EBITDA achievement of $553k
Proven software development team in niche dental imaging market
Career management experience in the dental, DSO and government market segments
Substantial customer base of existing VELscope and Apteryx customers
Significant IP portfolio – 40 issued digital imaging related patents
A Compelling Investment
Capitalization and Share Information
Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May$0.30
$0.40
$0.50
0200400
As of: May 17, 2019
Volume (Thousands) Price (CAD)
Exchange Listings:
LMD on TSX-VLEDIF on OTCQB
Trailing 12-month Price and Volume
Note: additional 12,000 common shares issuable under the Deferred Share Unit plan
Trading Stats
Last Close (May 29):$0.37
YTD Price Change:9.6%
52wk High/Low:$0.56 - 0.29
12
Ownership Summary
11%
10%79%
Other Shareholders
InstitutionalHolders
Management /Insiders
41%
6%
94%
Basic Shares O/S Fully-diluted (Prefs. Converted)
13
Investor Relations ContactDavid GaneTel: 604-434-4614 [email protected]
580 Hornby Street, Unit 810 Vancouver, British Columbia V6C 2E7 844.952.7327 | www.ledapteryx.com
